EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Adjunct-to-insulin therapy using SGLT2 inhibitors in youth with type 1 diabetes: a randomized controlled trial

Mahmud FH, Bjornstad P, Clarson C, Clarke A, Anthony SJ, Curtis J, et al

Yearbook of Paediatric Endocrinology · 30.09.2025

DOI: 10.1530/ey.22.10.3 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von Mahmud FH und 6 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

FH, M., P, B., C, C., A, C., SJ, A., J, C., & al, E. (2025). Adjunct-to-insulin therapy using SGLT2 inhibitors in youth with type 1 diabetes: a randomized controlled trial. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.10.3

Vancouver

FH M, P B, C C, A C, SJ A, J C, et al. Adjunct-to-insulin therapy using SGLT2 inhibitors in youth with type 1 diabetes: a randomized controlled trial. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.10.3

BibTeX
@article{FH2025,
  author = {FH, Mahmud and P, Bjornstad and C, Clarson and A, Clarke and SJ, Anthony and J, Curtis and al, et},
  title = {Adjunct-to-insulin therapy using SGLT2 inhibitors in youth with type 1 diabetes: a randomized controlled trial},
  journal = {Yearbook of Paediatric Endocrinology},
  year = {2025},
  doi = {10.1530/ey.22.10.3}
}
Kostenlos starten →